BioCure is currently planning the development of a pipeline of innovative products in order to establish leadership of the embolotherapy market.

One of our first product concepts was to develop a safe and easy to use liquid embolic which was viewed in our research as a clear and crucial market need by the medical professional and would serve a large population of untreated patients.

Why a liquid embolic? Most physicians and industry commentators view the need for a safe and easy to use liquid embolic as the idealized product in the evolution of the trend to provide greater density of filling material during embolization. This allows safer and more effective blockage of the blood vessel as well as enhanced targeting by the physician at the optimal site.

We are pleased to introduce a revolutionary new product planned for introduction in 2002*

LiquiGel ™ Embolic Agent

The first effective, easy-to-use, non-toxic liquid embolic agent providing a clog-free targeted embolization for a range of embolization indications*. In its initial format, it will be most suited to peripheral embolization.

*investigations are planned

Please contact us if you have any questions. We'd be happy to provide you with more information.